Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer

Table 1

The expression of EVL and clinicopathologic features in 79 pancreatic cancer patients.

Characteristics	EVL		value (χ2 test)
	Low expression	High expression
Age			0.010
≦60	6	16
>60	34	23
Gender			0.556
Male	18	15
Female	22	24
T classification			0.417
I, II	21	24
III, IV	19	15
N classification			0.516
No	26	28
Yes	14	11
Metastasis			1.000
No	37	37
Yes	3	2
Clinical stage			0.260
I, II	31	34
III, IV	9	5
Pathological differentiation		0.007
1, 2	19	30
3, 4	21	9
Vessel invasion			0.106
No	33	26
Yes	7	13
Nerve invasion			0.406
No	9	12
Yes	31	27